Wave Life Sciences
WVE
$5.88
Share price
3.70%
Change (1 day)
59.78%
Change (1 year)
Categories
Operating Margin for Wave Life Sciences (WVE)
Operating Margin as of May 2024 (TTM): -1,044.71%
According to Wave Life Sciences's latest financial reports and stock price the company's current Operating Margin is -1,044.71%. At the end of 2021 the company had an Operating Margin of -310.07%.
Operating Margin history for Wave Life Sciences from 2016 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -310.07% | -59.41% |
| 2020 | -763.94% | -41.39% |
| 2019 | -1,303.37% | 17.77% |
| 2018 | -1,106.72% | -60.04% |
| 2017 | -2,769.44% | -25.67% |
| 2016 | -3,725.72% | -70.65% |
| 2015 | -12,696.05% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.